DossierENTITY

FDA committee

Coverage of FDA committee in the Nexus archive.

Earliest in view: Jun 19 · 00:43 UTCMost recent: Jun 19 · 00:43 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 19 · 00:43 UTCNPR HEALTH
Key FDA committee unanimously recommends its first vaccine since 2023
A key FDA committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over. The recommendation marks the committee's first vaccine approval since 2023.
HEALTHJun 19 · 00:43 UTCNPR NEWS
Key FDA committee unanimously recommends its first vaccine since 2023
A key FDA committee unanimously recommended Moderna's new mRNA influenza vaccine for adults aged 50 and over. All nine committee members voted in favor of the recommendation.